Figure 1
From: NCBP1 enhanced proliferation of DLBCL cells via METTL3-mediated m6A modification of c-Myc
NCBP1 was overexpressed in the lymph nodes of DLBCL patients and was related to their poor prognosis. (A) NCBP1 expression in DLBCL tumors and normal tissues from the GEPIA database. (B) NCBP1 expression was measured in 50 DLBCL tissues and 14 inflammatory lymph nodes by quantitative RT‒PCR. (C) Overall survival of patients grouped by NCBP1 expression as either high (red) or low (blue) in DLBCL patients. High NCBP1 expression was considered to correlate with a short survival time. The results represent the mean ± SD; *P < 0.05; **P < 0.01, ***P < 0.001.
